TABLE 6.
HCV infection status in relation to CLIA s/co ratio
| CLIA and s/co ratio | No. of cases in each group | No. (%) of cases with HCV infection |
|---|---|---|
| Elecsys | ||
| 1-200 | 13 | 5 (38.5) |
| 200-400 | 24 | 21 (87.5) |
| 400-1,000 | 56 | 55 (98.2) |
| >1,000 | 13 | 13 (100) |
| Total | 106 | 94 (88.7) |
| Architect | ||
| 1.0-3.0 | 14 | 1 (7.1) |
| 3.0-10.0 | 12 | 7 (58.3) |
| 10.0-15.0 | 68 | 68 (100) |
| >15.0 | 18 | 18 (100) |
| Total | 112 | 94 (83.9) |
| Vitros | ||
| 1.0-8.0 | 17 | 1 (5.9) |
| 8.0-20.0 | 6 | 4 (66.7) |
| 20.0-30.0 | 56 | 56 (100) |
| >30.0 | 7 | 7 (100) |
| Total | 86 | 68 (79.1) |
| Access | ||
| 1.0-3.0 | 17 | 1 (5.9) |
| 3.0-10.0 | 13 | 9 (69.2) |
| 10.0-15.0 | 75 | 74 (98.7) |
| >15.0 | 7 | 7 (100) |
| Total | 112 | 91 (81.3) |